These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3552820)

  • 21. [The results of a comparative study of the lipid peroxidation processes and of the malondialdehyde level of the blood cells in patients with diabetic angiopathies and during insulin therapy].
    Rud'ko IA; Balashova TS; Golega EN; Balabolkin MI; Kubatiev AA
    Ter Arkh; 1994; 66(10):27-9. PubMed ID: 7863440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulin-substitute therapy in diabetes mellitus].
    Genes SG
    Ter Arkh; 1977; 49(12):126-31. PubMed ID: 341400
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Diabetes Reserach in Children Network (DirecNet) Study Group
    Diabetes Care; 2007 Jan; 30(1):185; author reply 187-9. PubMed ID: 17192364
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Service FJ; O'Brien PC
    Diabetes Care; 2007 Jan; 30(1):186; author reply 187-8. PubMed ID: 17192366
    [No Abstract]   [Full Text] [Related]  

  • 25. Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? The Diabetes Control and Complications Trial.
    DCCT Research Group
    N Engl J Med; 1988 Jan; 318(4):246-50. PubMed ID: 3336413
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin-dependent diabetes mellitus: pathophysiology.
    Gerich JE
    Mayo Clin Proc; 1986 Oct; 61(10):787-91. PubMed ID: 3528691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes control and complications. Where do we go from here?
    Ratner RE
    Online J Curr Clin Trials; 1993 Jun; Doc No 68():[996 words; 6 paragraphs]. PubMed ID: 8313018
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth hormone in insulin-treated diabetes mellitus.
    Sabeh G; Mendelsohn LV; Corredor DG; Sunder JH; Friedman LM; Morgan CR; Danowski TS
    Metabolism; 1969 Sep; 18(9):748-53. PubMed ID: 5343866
    [No Abstract]   [Full Text] [Related]  

  • 29. Glycaemic control and microvascular complication among patients with youth onset diabetes in India using differing types of insulin and methods of glucose monitoring.
    Miglani S; Goswami R; Tandon N; Dudha A; Kochupillai N
    Diabetes Res Clin Pract; 2004 Aug; 65(2):183-5. PubMed ID: 15223231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of the DCCT trial. Implications for managing our patients with diabetes.
    Worrall G
    Can Fam Physician; 1994 Nov; 40():1955-60, 1963-5. PubMed ID: 7841827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive insulin therapy can delay long-term complications of diabetes, study shows.
    Am J Hosp Pharm; 1994 Jan; 51(1):13. PubMed ID: 8135256
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease.
    Uruska A; Araszkiewicz A; Zozulinska-Ziolkiewicz D; Uruski P; Wierusz-Wysocka B
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):478-84. PubMed ID: 20373280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The case for blood glucose control.
    Genuth SM
    Adv Intern Med; 1995; 40():573-623. PubMed ID: 7747658
    [No Abstract]   [Full Text] [Related]  

  • 34. Does normalization of blood glucose reduce the complications of diabetes?
    Vajdos MA; Gilliland PF
    South Med J; 1995 Mar; 88(3):372-5. PubMed ID: 7886542
    [No Abstract]   [Full Text] [Related]  

  • 35. Lessons from the Diabetes Control and Complications Trial.
    Santiago JV
    Diabetes; 1993 Nov; 42(11):1549-54. PubMed ID: 8405693
    [No Abstract]   [Full Text] [Related]  

  • 36. Study: tight glucose control in diabetes lowers risk of atherosclerosis.
    FDA Consum; 2003; 37(4):10. PubMed ID: 12971340
    [No Abstract]   [Full Text] [Related]  

  • 37. Intensive insulin treatment in diabetic children.
    Ludvigsson J; Bolli GB
    Diabetes Nutr Metab; 2001 Oct; 14(5):292-304. PubMed ID: 11806471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood glucose control and diabetic complications.
    Raskin P; Rosenstock J
    Ann Intern Med; 1986 Aug; 105(2):254-63. PubMed ID: 3524339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin infusion systems, diabetic control, and microvascular complications.
    Watkins PJ
    Br Med J; 1980 Feb; 280(6211):350-2. PubMed ID: 6988037
    [No Abstract]   [Full Text] [Related]  

  • 40. The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus.
    Martin FI; Hopper JL
    Diabetologia; 1987 Mar; 30(3):149-53. PubMed ID: 3556289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.